[Computed tomography after administration of SMANCS-lipiodol to liver cancers].
D000328:Adult; D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000000981:diagnostic imaging* / Q000188:drug therapy; D005260:Female; D005663:Furans / Q000627:therapeutic use*; D006499:Hepatic Artery; D006801:Humans; D007261:Infusions, Intra-Arterial; D007459:Iodized Oil / Q000627:therapeutic use*; D008113:Liver Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000556:secondary; D008297:Male; D008299:Maleic Anhydrides / Q000627:therapeutic use*; D008875:Middle Aged; D011137:Polystyrenes / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed; D009353:Zinostatin / Q000031:analogs & derivatives / Q000627:therapeutic use*
D000903:Antibiotics, Antineoplastic; D005663:Furans; D008299:Maleic Anhydrides; D011137:Polystyrenes; C035755:poly(maleic acid-styrene)neocarzinostatin; D007459:Iodized Oil; D009353:Zinostatin